Skip to main content
Top
Published in: BMC Infectious Diseases 1/2011

Open Access 01-12-2011 | Research article

Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza

Authors: Raquel Almansa, Andres Anton, Paula Ramirez, Ignacio Martin-Loeches, David Banner, Tomás Pumarola, Luoling Xu, Jesús Blanco, Longsi Ran, Guillermo Lopez-Campos, Fernando Martin-Sanchez, Lorenzo Socias, Ana Loza, David Andaluz, Enrique Maravi, Mónica Gordón, Maria C Gallegos, Victoria Fernandez, Cristobal León, Pedro Merino, Maria Ángeles Marcos, Francisco Gandía, Felipe Bobillo, Salvador Resino, Jose Mª Eiros, Carmen Castro, Paula Mateo, Milagros Gonzalez-Rivera, Jordi Rello, Raul Ortiz de Lejarazu, David J Kelvin, Jesus F Bermejo-Martin

Published in: BMC Infectious Diseases | Issue 1/2011

Login to get access

Abstract

Background

Severe disease caused by 2009 pandemic influenza A/H1N1virus is characterized by the presence of hypercytokinemia. The origin of the exacerbated cytokine response is unclear. As observed previously, uncontrolled influenza virus replication could strongly influence cytokine production. The objective of the present study was to evaluate the relationship between host cytokine responses and viral levels in pandemic influenza critically ill patients.

Methods

Twenty three patients admitted to the ICU with primary viral pneumonia were included in this study. A quantitative PCR based method targeting the M1 influenza gene was developed to quantify pharyngeal viral load. In addition, by using a multiplex based assay, we systematically evaluated host cytokine responses to the viral infection at admission to the ICU. Correlation studies between cytokine levels and viral load were done by calculating the Spearman correlation coefficient.

Results

Fifteen patients needed of intubation and ventilation, while eight did not need of mechanical ventilation during ICU hospitalization. Viral load in pharyngeal swabs was 300 fold higher in the group of patients with the worst respiratory condition at admission to the ICU. Pharyngeal viral load directly correlated with plasma levels of the pro-inflammatory cytokines IL-6, IL-12p70, IFN-γ, the chemotactic factors MIP-1β, GM-CSF, the angiogenic mediator VEGF and also of the immuno-modulatory cytokine IL-1ra (p < 0.05). Correlation studies demonstrated also the existence of a significant positive association between the levels of these mediators, evidencing that they are simultaneously regulated in response to the virus.

Conclusions

Severe respiratory disease caused by the 2009 pandemic influenza virus is characterized by the existence of a direct association between viral replication and host cytokine response, revealing a potential pathogenic link with the severe disease caused by other influenza subtypes such as H5N1.
Appendix
Available only for authorised users
Literature
1.
go back to reference Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, et al: Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010, 362 (18): 1708-1719.CrossRefPubMed Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, Uyeki TM, Zaki SR, Hayden FG, Hui DS, Kettner JD, et al: Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med. 2010, 362 (18): 1708-1719.CrossRefPubMed
2.
go back to reference Maravi-Poma E, Martin-Loeches I, Regidor E, Laplaza C, Cambra K, Aldunate S, Guerrero JE, Loza-Vazquez A, Arnau E, Almirall J, et al: Severe 2009 H1N1 influenza in pregnant women in Spain. Crit Care Med. 2011, 39 (5): 945-951. 10.1097/CCM.0b013e318208ee12.CrossRefPubMed Maravi-Poma E, Martin-Loeches I, Regidor E, Laplaza C, Cambra K, Aldunate S, Guerrero JE, Loza-Vazquez A, Arnau E, Almirall J, et al: Severe 2009 H1N1 influenza in pregnant women in Spain. Crit Care Med. 2011, 39 (5): 945-951. 10.1097/CCM.0b013e318208ee12.CrossRefPubMed
3.
go back to reference To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, Liu R, Ho KY, Chu KH, Watt CL, et al: Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. 2010, 50 (6): 850-859. 10.1086/650581.CrossRefPubMed To KK, Hung IF, Li IW, Lee KL, Koo CK, Yan WW, Liu R, Ho KY, Chu KH, Watt CL, et al: Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis. 2010, 50 (6): 850-859. 10.1086/650581.CrossRefPubMed
4.
go back to reference Giannella M, Alonso M, Garcia de Viedma D, Roa PL, Catalan P, Padilla B, Munoz P, Bouza E: Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients. Clin Microbiol Infect. 2010, 17: 1160-1165.CrossRefPubMed Giannella M, Alonso M, Garcia de Viedma D, Roa PL, Catalan P, Padilla B, Munoz P, Bouza E: Prolonged viral shedding in pandemic influenza A(H1N1): clinical significance and viral load analysis in hospitalized patients. Clin Microbiol Infect. 2010, 17: 1160-1165.CrossRefPubMed
5.
go back to reference Lee N, Chan PK, Wong CK, Wong KT, Choi KW, Joynt GM, Lam P, Chan MC, Wong BC, Lui GC, et al: Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia. Antivir Ther. 2011, 16 (2): 237-247. 10.3851/IMP1722.CrossRefPubMed Lee N, Chan PK, Wong CK, Wong KT, Choi KW, Joynt GM, Lam P, Chan MC, Wong BC, Lui GC, et al: Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia. Antivir Ther. 2011, 16 (2): 237-247. 10.3851/IMP1722.CrossRefPubMed
6.
go back to reference Ramsey C, Kumar A: H1N1: viral pneumonia as a cause of acute respiratory distress syndrome. Curr Opin Crit Care. 2011, 17 (1): 64-71. 10.1097/MCC.0b013e3283427259.CrossRefPubMed Ramsey C, Kumar A: H1N1: viral pneumonia as a cause of acute respiratory distress syndrome. Curr Opin Crit Care. 2011, 17 (1): 64-71. 10.1097/MCC.0b013e3283427259.CrossRefPubMed
7.
go back to reference Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramirez P, Martin-Loeches I, Varillas D, Gallegos MC, Seron C, et al: Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care. 2009, 13 (6): R201-10.1186/cc8208.CrossRefPubMedPubMedCentral Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, Ramirez P, Martin-Loeches I, Varillas D, Gallegos MC, Seron C, et al: Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care. 2009, 13 (6): R201-10.1186/cc8208.CrossRefPubMedPubMedCentral
8.
go back to reference Hagau N, Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, Brezoszki ES, Maxim M, Ciuce C, Mlesnite M, Gavrus RL, et al: Clinical aspects and cytokines response in severe H1N1 influenza A virus infection. Crit Care. 2010, 14 (6): R203-10.1186/cc9324.CrossRefPubMedPubMedCentral Hagau N, Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, Brezoszki ES, Maxim M, Ciuce C, Mlesnite M, Gavrus RL, et al: Clinical aspects and cytokines response in severe H1N1 influenza A virus infection. Crit Care. 2010, 14 (6): R203-10.1186/cc9324.CrossRefPubMedPubMedCentral
9.
go back to reference Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, Garcia-Sastre A, Tolnay AE, Albrecht R, Pyles JA, Olson PH, et al: Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci USA. 2009, 106 (9): 3455-3460. 10.1073/pnas.0813234106.CrossRefPubMedPubMedCentral Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, Garcia-Sastre A, Tolnay AE, Albrecht R, Pyles JA, Olson PH, et al: Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci USA. 2009, 106 (9): 3455-3460. 10.1073/pnas.0813234106.CrossRefPubMedPubMedCentral
10.
go back to reference Peiris JS, Hui KP, Yen HL: Host response to influenza virus: protection versus immunopathology. Curr Opin Immunol. 2010, 22 (4): 475-481. 10.1016/j.coi.2010.06.003.CrossRefPubMedPubMedCentral Peiris JS, Hui KP, Yen HL: Host response to influenza virus: protection versus immunopathology. Curr Opin Immunol. 2010, 22 (4): 475-481. 10.1016/j.coi.2010.06.003.CrossRefPubMedPubMedCentral
11.
go back to reference Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, Cameron CM, Muller MP, Gold WL, Richardson SE, Poutanen SM, et al: Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol. 2007, 81 (16): 8692-8706. 10.1128/JVI.00527-07.CrossRefPubMedPubMedCentral Cameron MJ, Ran L, Xu L, Danesh A, Bermejo-Martin JF, Cameron CM, Muller MP, Gold WL, Richardson SE, Poutanen SM, et al: Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome. J Virol. 2007, 81 (16): 8692-8706. 10.1128/JVI.00527-07.CrossRefPubMedPubMedCentral
12.
go back to reference Cameron CM, Cameron MJ, Bermejo-Martin JF, Ran L, Xu L, Turner PV, Ran R, Danesh A, Fang Y, Chan PK, et al: Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets. J Virol. 2008, 82 (22): 11308-11317. 10.1128/JVI.00691-08.CrossRefPubMedPubMedCentral Cameron CM, Cameron MJ, Bermejo-Martin JF, Ran L, Xu L, Turner PV, Ran R, Danesh A, Fang Y, Chan PK, et al: Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets. J Virol. 2008, 82 (22): 11308-11317. 10.1128/JVI.00691-08.CrossRefPubMedPubMedCentral
13.
go back to reference de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, et al: Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006, 12 (10): 1203-1207. 10.1038/nm1477.CrossRefPubMedPubMedCentral de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, Chau TN, Hoang DM, Chau NV, Khanh TH, Dong VC, et al: Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med. 2006, 12 (10): 1203-1207. 10.1038/nm1477.CrossRefPubMedPubMedCentral
14.
go back to reference Suwannakarn K, Payungporn S, Chieochansin T, Samransamruajkit R, Amonsin A, Songserm T, Chaisingh A, Chamnanpood P, Chutinimitkul S, Theamboonlers A, et al: Typing (A/B) and subtyping (H1/H3/H5) of influenza A viruses by multiplex real-time RT-PCR assays. J Virol Methods. 2008, 152 (1-2): 25-31. 10.1016/j.jviromet.2008.06.002.CrossRefPubMed Suwannakarn K, Payungporn S, Chieochansin T, Samransamruajkit R, Amonsin A, Songserm T, Chaisingh A, Chamnanpood P, Chutinimitkul S, Theamboonlers A, et al: Typing (A/B) and subtyping (H1/H3/H5) of influenza A viruses by multiplex real-time RT-PCR assays. J Virol Methods. 2008, 152 (1-2): 25-31. 10.1016/j.jviromet.2008.06.002.CrossRefPubMed
15.
go back to reference Lennette ET BA, Hansler WJ, Shadomy HJ: Manual of Clinical Microbiology, Washington, DC. American Society for Microbiology. 1985, 160-200. Lennette ET BA, Hansler WJ, Shadomy HJ: Manual of Clinical Microbiology, Washington, DC. American Society for Microbiology. 1985, 160-200.
16.
go back to reference Kendal AP, P M, Skehel JJ: Concepts and procedures for laboratory-based influenza surveillance. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta, Georgia. 1982 Kendal AP, P M, Skehel JJ: Concepts and procedures for laboratory-based influenza surveillance. US Department of Health and Human Services, Public Health Service, Centers for Disease Control, Atlanta, Georgia. 1982
17.
go back to reference Bermejo-Martin JF, Martin-Loeches I, Rello J, Anton A, Almansa R, Xu L, Lopez-Campos G, Pumarola T, Ran L, Ramirez P, et al: Host adaptive immunity deficiency in severe pandemic influenza. Crit Care. 2010, 14 (5): R167-10.1186/cc9259.CrossRefPubMedPubMedCentral Bermejo-Martin JF, Martin-Loeches I, Rello J, Anton A, Almansa R, Xu L, Lopez-Campos G, Pumarola T, Ran L, Ramirez P, et al: Host adaptive immunity deficiency in severe pandemic influenza. Crit Care. 2010, 14 (5): R167-10.1186/cc9259.CrossRefPubMedPubMedCentral
18.
go back to reference Lee N, Chan PK, Hui DS, Rainer TH, Wong E, Choi KW, Lui GC, Wong BC, Wong RY, Lam WY, et al: Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis. 2009, 200 (4): 492-500. 10.1086/600383.CrossRefPubMed Lee N, Chan PK, Hui DS, Rainer TH, Wong E, Choi KW, Lui GC, Wong BC, Wong RY, Lam WY, et al: Viral loads and duration of viral shedding in adult patients hospitalized with influenza. J Infect Dis. 2009, 200 (4): 492-500. 10.1086/600383.CrossRefPubMed
19.
go back to reference Strieter RM, Belperio JA, Keane MP: Host innate defenses in the lung: the role of cytokines. Curr Opin Infect Dis. 2003, 16 (3): 193-198. 10.1097/00001432-200306000-00002.CrossRefPubMed Strieter RM, Belperio JA, Keane MP: Host innate defenses in the lung: the role of cytokines. Curr Opin Infect Dis. 2003, 16 (3): 193-198. 10.1097/00001432-200306000-00002.CrossRefPubMed
20.
go back to reference Hamza T, Barnett JB, Li B: Interleukin 12 a key immunoregulatory cytokine in infection applications. Int J Mol Sci. 2010, 11 (3): 789-806. 10.3390/ijms11030789.CrossRefPubMedPubMedCentral Hamza T, Barnett JB, Li B: Interleukin 12 a key immunoregulatory cytokine in infection applications. Int J Mol Sci. 2010, 11 (3): 789-806. 10.3390/ijms11030789.CrossRefPubMedPubMedCentral
21.
go back to reference Powell ND, Mays JW, Bailey MT, Hanke ML, Sheridan JF: Immunogenic dendritic cells primed by social defeat enhance adaptive immunity to influenza A virus. Brain Behav Immun. 2011, 25 (1): 46-52. 10.1016/j.bbi.2010.07.243.CrossRefPubMed Powell ND, Mays JW, Bailey MT, Hanke ML, Sheridan JF: Immunogenic dendritic cells primed by social defeat enhance adaptive immunity to influenza A virus. Brain Behav Immun. 2011, 25 (1): 46-52. 10.1016/j.bbi.2010.07.243.CrossRefPubMed
22.
go back to reference Pavlisa G, Pavlisa G, Kusec V, Kolonic SO, Markovic AS, Jaksic B: Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD. Eur Cytokine Netw. 2010, 21 (2): 92-98.PubMed Pavlisa G, Pavlisa G, Kusec V, Kolonic SO, Markovic AS, Jaksic B: Serum levels of VEGF and bFGF in hypoxic patients with exacerbated COPD. Eur Cytokine Netw. 2010, 21 (2): 92-98.PubMed
23.
go back to reference Kilani MM, Mohammed KA, Nasreen N, Hardwick JA, Kaplan MH, Tepper RS, Antony VB: Respiratory syncytial virus causes increased bronchial epithelial permeability. Chest. 2004, 126 (1): 186-191. 10.1378/chest.126.1.186.CrossRefPubMed Kilani MM, Mohammed KA, Nasreen N, Hardwick JA, Kaplan MH, Tepper RS, Antony VB: Respiratory syncytial virus causes increased bronchial epithelial permeability. Chest. 2004, 126 (1): 186-191. 10.1378/chest.126.1.186.CrossRefPubMed
24.
go back to reference Venteclef N, Delerive P: Interleukin-1 receptor antagonist induction as an additional mechanism for liver receptor homolog-1 to negatively regulate the hepatic acute phase response. J Biol Chem. 2007, 282 (7): 4393-4399.CrossRefPubMed Venteclef N, Delerive P: Interleukin-1 receptor antagonist induction as an additional mechanism for liver receptor homolog-1 to negatively regulate the hepatic acute phase response. J Biol Chem. 2007, 282 (7): 4393-4399.CrossRefPubMed
25.
go back to reference Ratta M, Fagnoni F, Curti A, Vescovini R, Sansoni P, Oliviero B, Fogli M, Ferri E, Della Cuna GR, Tura S, et al: Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. Blood. 2002, 100 (1): 230-237. 10.1182/blood.V100.1.230.CrossRefPubMed Ratta M, Fagnoni F, Curti A, Vescovini R, Sansoni P, Oliviero B, Fogli M, Ferri E, Della Cuna GR, Tura S, et al: Dendritic cells are functionally defective in multiple myeloma: the role of interleukin-6. Blood. 2002, 100 (1): 230-237. 10.1182/blood.V100.1.230.CrossRefPubMed
26.
go back to reference Agrati C, Gioia C, Lalle E, Cimini E, Castilletti C, Armignacco O, Lauria FN, Ferraro F, Antonini M, Ippolito G, et al: Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course. J Infect Dis. 2010, 202 (5): 681-689. 10.1086/655469.CrossRefPubMed Agrati C, Gioia C, Lalle E, Cimini E, Castilletti C, Armignacco O, Lauria FN, Ferraro F, Antonini M, Ippolito G, et al: Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course. J Infect Dis. 2010, 202 (5): 681-689. 10.1086/655469.CrossRefPubMed
27.
go back to reference Uchide N, Ohyama K, Bessho T, Toyoda H: Induction of pro-inflammatory cytokine gene expression and apoptosis in human chorion cells of fetal membranes by influenza virus infection: possible implications for maintenance and interruption of pregnancy during infection. Med Sci Monit. 2005, 11 (1): RA7-16.PubMed Uchide N, Ohyama K, Bessho T, Toyoda H: Induction of pro-inflammatory cytokine gene expression and apoptosis in human chorion cells of fetal membranes by influenza virus infection: possible implications for maintenance and interruption of pregnancy during infection. Med Sci Monit. 2005, 11 (1): RA7-16.PubMed
28.
go back to reference Smith AG, Sheridan PA, Tseng RJ, Sheridan JF, Beck MA: Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus. Immunology. 2009, 126 (2): 268-279. 10.1111/j.1365-2567.2008.02895.x.CrossRefPubMedPubMedCentral Smith AG, Sheridan PA, Tseng RJ, Sheridan JF, Beck MA: Selective impairment in dendritic cell function and altered antigen-specific CD8+ T-cell responses in diet-induced obese mice infected with influenza virus. Immunology. 2009, 126 (2): 268-279. 10.1111/j.1365-2567.2008.02895.x.CrossRefPubMedPubMedCentral
29.
go back to reference Kang MJ, Lee CG, Lee JY, Dela Cruz CS, Chen ZJ, Enelow R, Elias JA: Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest. 2008, 118 (8): 2771-2784.PubMedPubMedCentral Kang MJ, Lee CG, Lee JY, Dela Cruz CS, Chen ZJ, Enelow R, Elias JA: Cigarette smoke selectively enhances viral PAMP- and virus-induced pulmonary innate immune and remodeling responses in mice. J Clin Invest. 2008, 118 (8): 2771-2784.PubMedPubMedCentral
30.
go back to reference Jaecklin T, Otulakowski G, Kavanagh BP: Do soluble mediators cause ventilator-induced lung injury and multi-organ failure?. Intensive Care Med. 2010, 36 (5): 750-757. 10.1007/s00134-010-1850-4.CrossRefPubMed Jaecklin T, Otulakowski G, Kavanagh BP: Do soluble mediators cause ventilator-induced lung injury and multi-organ failure?. Intensive Care Med. 2010, 36 (5): 750-757. 10.1007/s00134-010-1850-4.CrossRefPubMed
31.
go back to reference Martin-Loeches I, Lisboa T, Rhodes A, Moreno RP, Silva E, Sprung C, Chiche JD, Barahona D, Villabon M, Balasini C, et al: Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med. 2011, 37 (2): 272-283. 10.1007/s00134-010-2078-z.CrossRefPubMed Martin-Loeches I, Lisboa T, Rhodes A, Moreno RP, Silva E, Sprung C, Chiche JD, Barahona D, Villabon M, Balasini C, et al: Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Intensive Care Med. 2011, 37 (2): 272-283. 10.1007/s00134-010-2078-z.CrossRefPubMed
32.
go back to reference Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, Lee YJ, Lee HB, Lim CM, Koh Y: Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med. 2011, 183 (9): 1207-1214. 10.1164/rccm.201101-0110OC.CrossRefPubMed Kim SH, Hong SB, Yun SC, Choi WI, Ahn JJ, Lee YJ, Lee HB, Lim CM, Koh Y: Corticosteroid treatment in critically ill patients with pandemic influenza A/H1N1 2009 infection: analytic strategy using propensity scores. Am J Respir Crit Care Med. 2011, 183 (9): 1207-1214. 10.1164/rccm.201101-0110OC.CrossRefPubMed
33.
go back to reference Kilander A, Rykkvin R, Dudman SG, Hungnes O: Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill. 2010, 15 (9): Kilander A, Rykkvin R, Dudman SG, Hungnes O: Observed association between the HA1 mutation D222G in the 2009 pandemic influenza A(H1N1) virus and severe clinical outcome, Norway 2009-2010. Euro Surveill. 2010, 15 (9):
34.
go back to reference Drews SJ, Pabbaraju K, Wong S, Tokaryk KL, May-Hadford J, Lee B, Tellier R, Louie M: Surveillance of autopsy cases for the D222G substitutions in the haemagglutinin (HA) protein of Pandemic (H1N1) 2009 virus in Alberta, Canada. Clin Microbiol Infect. 2010, 17 (4): 582-584.CrossRefPubMed Drews SJ, Pabbaraju K, Wong S, Tokaryk KL, May-Hadford J, Lee B, Tellier R, Louie M: Surveillance of autopsy cases for the D222G substitutions in the haemagglutinin (HA) protein of Pandemic (H1N1) 2009 virus in Alberta, Canada. Clin Microbiol Infect. 2010, 17 (4): 582-584.CrossRefPubMed
Metadata
Title
Direct association between pharyngeal viral secretion and host cytokine response in severe pandemic influenza
Authors
Raquel Almansa
Andres Anton
Paula Ramirez
Ignacio Martin-Loeches
David Banner
Tomás Pumarola
Luoling Xu
Jesús Blanco
Longsi Ran
Guillermo Lopez-Campos
Fernando Martin-Sanchez
Lorenzo Socias
Ana Loza
David Andaluz
Enrique Maravi
Mónica Gordón
Maria C Gallegos
Victoria Fernandez
Cristobal León
Pedro Merino
Maria Ángeles Marcos
Francisco Gandía
Felipe Bobillo
Salvador Resino
Jose Mª Eiros
Carmen Castro
Paula Mateo
Milagros Gonzalez-Rivera
Jordi Rello
Raul Ortiz de Lejarazu
David J Kelvin
Jesus F Bermejo-Martin
Publication date
01-12-2011
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2011
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/1471-2334-11-232

Other articles of this Issue 1/2011

BMC Infectious Diseases 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine